192 related articles for article (PubMed ID: 34529789)
1. Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?
Imber BS; Chau KW; Lee J; Lee J; Casey DL; Yang JC; Wijentunga NA; Shepherd A; Hajj C; Qi S; Chelius MR; Hamlin PA; Palomba ML; Joffe E; Zhang Z; Zelenetz AD; Salles GA; Yahalom J
Blood Adv; 2021 Oct; 5(20):4185-4197. PubMed ID: 34529789
[TBL] [Abstract][Full Text] [Related]
2. 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial.
Hoskin P; Popova B; Schofield O; Brammer C; Robinson M; Brunt AM; Madhavan K; Illidge T; Gallop-Evans E; Syndikus I; Clifton-Hadley L; Kirkwood AA
Lancet Oncol; 2021 Mar; 22(3):332-340. PubMed ID: 33539729
[TBL] [Abstract][Full Text] [Related]
3. Very low-dose radiotherapy for extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue.
Freret ME; Tringale KR; Boe L; Imber BS; Joffe E; Yahalom J; Hajj C
Leuk Lymphoma; 2023 Dec; 64(13):2195-2201. PubMed ID: 37706509
[TBL] [Abstract][Full Text] [Related]
4. Low-grade non-hodgkin lymphomas.
Tsang RW; Gospodarowicz MK
Semin Radiat Oncol; 2007 Jul; 17(3):198-205. PubMed ID: 17591567
[TBL] [Abstract][Full Text] [Related]
5. 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial.
Hoskin PJ; Kirkwood AA; Popova B; Smith P; Robinson M; Gallop-Evans E; Coltart S; Illidge T; Madhavan K; Brammer C; Diez P; Jack A; Syndikus I
Lancet Oncol; 2014 Apr; 15(4):457-63. PubMed ID: 24572077
[TBL] [Abstract][Full Text] [Related]
6. Palliation by low-dose local radiation therapy for indolent non-Hodgkin lymphoma.
Chan EK; Fung S; Gospodarowicz M; Hodgson D; Wells W; Sun A; Pintile M; Tsang RW
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e781-6. PubMed ID: 21167657
[TBL] [Abstract][Full Text] [Related]
7. Low grade, indolent lymphomas of the head and neck: Comparative toxicity of standard versus very low dose radiation therapy.
Chelius M; Chau K; Yang J; Hajj C; Imber B; Yahalom J
Hematol Oncol; 2021 Aug; 39(3):304-312. PubMed ID: 33733514
[TBL] [Abstract][Full Text] [Related]
8. De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma.
Oertel M; Elsayad K; Weishaupt C; Steinbrink K; Eich HT
Strahlenther Onkol; 2020 Feb; 196(2):126-131. PubMed ID: 31758232
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy for localized low-grade non-Hodgkin's lymphomas.
Tsang RW; Gospodarowicz MK
Hematol Oncol; 2005 Mar; 23(1):10-7. PubMed ID: 16158458
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients.
Elsayad K; Reinartz G; Oertel M; Rehn S; Eismann J; Scobioala S; Berssenbrügge H; Eter N; Weishaupt C; Schmidt HH; Friedrichs B; Grünewald I; Hartmann W; Lenz G; Wardelmann E; Willich N; Eich HT
Strahlenther Onkol; 2020 Feb; 196(2):117-125. PubMed ID: 31732783
[TBL] [Abstract][Full Text] [Related]
11. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
12. Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas.
Saleh K; Michot JM; Schernberg A; Lazarovici J; Chahine C; Danu A; Khalife-Saleh N; Rossignol J; Ghez D; Martin V; Mazeron R; Fermé C; Boros A; Ribrag V; Girinsky T
Cancer Med; 2020 Jun; 9(11):3725-3732. PubMed ID: 32249547
[TBL] [Abstract][Full Text] [Related]
13. Localized low-dose radiotherapy for follicular lymphoma: history, clinical results, mechanisms of action, and future outlooks.
Ganem G; Cartron G; Girinsky T; Haas RL; Cosset JM; Solal-Celigny P
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):975-82. PubMed ID: 20970029
[TBL] [Abstract][Full Text] [Related]
14. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes.
Fung CY; Tarbell NJ; Lucarelli MJ; Goldberg SI; Linggood RM; Harris NL; Ferry JA
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1382-91. PubMed ID: 14630277
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of radiation therapy of indolent cutaneous B-cell lymphomas and literature review.
Gauci ML; Quero L; Ram-Wolff C; Guillerm S; M'Barek B; Lebbé C; Bagot M; Hennequin C
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1668-1673. PubMed ID: 29578630
[TBL] [Abstract][Full Text] [Related]
16. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for orbital lymphoma.
Zhou P; Ng AK; Silver B; Li S; Hua L; Mauch PM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):866-71. PubMed ID: 15925453
[TBL] [Abstract][Full Text] [Related]
18. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
[TBL] [Abstract][Full Text] [Related]
19. Extranodal nonorbital indolent lymphomas of the head and neck: relationship between tumor control and radiotherapy.
MacDermed D; Thurber L; George TI; Hoppe RT; Le QT
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):788-95. PubMed ID: 15183482
[TBL] [Abstract][Full Text] [Related]
20. Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomas.
König L; Hörner-Rieber J; Bernhardt D; Hommertgen A; Rieken S; Debus J; Herfarth K
Strahlenther Onkol; 2018 May; 194(5):454-461. PubMed ID: 29450588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
